Neurovascular Thrombectomy Device Market Report

Global Neurovascular Thrombectomy Device Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 07, 2022
  • PAGES：146
  • REPORT CODE：GMM829083
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Neurovascular Thrombectomy Device market report explains the definition, types, applications, major countries, and major players of the Neurovascular Thrombectomy Device market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Spectranetics Corporation (US)

    • Penumbra, Inc (US)

    • Edwards Lifesciences Corporation (US)

    • Terumo Corporation (Japan)

    • Medtronic plc (Ireland)

    • Stryker Corporation (US)

    • Teleflex Incorporated (US)

    • Johnson & Johnson (US)

    • Argon Medical Devices, Inc (US)

    • Boston Scientific Corporation (US)

    By Type:

    • Mechanical/Fragmentation Thrombectomy Devices

    • Stent Retrievers

    • Basket/Brush Retrievers

    • Coil Retrievers

    • Aspiration Thrombectomy Devices

    • Rheolytic/Hydrodynamic Thrombectomy Devices

    • Ultrasonic Thrombectomy Devices

    By End-User:

    • Hospitals and Surgical Centers

    • Ambulatory Surgical Centers

    • Research Laboratories & Academic Institutes

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Neurovascular Thrombectomy Device Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Neurovascular Thrombectomy Device Outlook to 2028- Original Forecasts

    • 2.2 Neurovascular Thrombectomy Device Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Neurovascular Thrombectomy Device Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Neurovascular Thrombectomy Device Market- Recent Developments

    • 6.1 Neurovascular Thrombectomy Device Market News and Developments

    • 6.2 Neurovascular Thrombectomy Device Market Deals Landscape

    7 Neurovascular Thrombectomy Device Raw Materials and Cost Structure Analysis

    • 7.1 Neurovascular Thrombectomy Device Key Raw Materials

    • 7.2 Neurovascular Thrombectomy Device Price Trend of Key Raw Materials

    • 7.3 Neurovascular Thrombectomy Device Key Suppliers of Raw Materials

    • 7.4 Neurovascular Thrombectomy Device Market Concentration Rate of Raw Materials

    • 7.5 Neurovascular Thrombectomy Device Cost Structure Analysis

      • 7.5.1 Neurovascular Thrombectomy Device Raw Materials Analysis

      • 7.5.2 Neurovascular Thrombectomy Device Labor Cost Analysis

      • 7.5.3 Neurovascular Thrombectomy Device Manufacturing Expenses Analysis

    8 Global Neurovascular Thrombectomy Device Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Neurovascular Thrombectomy Device Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Neurovascular Thrombectomy Device Export by Region (Top 10 Countries) (2017-2028)

    9 Global Neurovascular Thrombectomy Device Market Outlook by Types and Applications to 2022

    • 9.1 Global Neurovascular Thrombectomy Device Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Mechanical/Fragmentation Thrombectomy Devices Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Stent Retrievers Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Basket/Brush Retrievers Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Coil Retrievers Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Aspiration Thrombectomy Devices Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Rheolytic/Hydrodynamic Thrombectomy Devices Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Ultrasonic Thrombectomy Devices Consumption and Growth Rate (2017-2022)

    • 9.2 Global Neurovascular Thrombectomy Device Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals and Surgical Centers Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Research Laboratories & Academic Institutes Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Neurovascular Thrombectomy Device Market Analysis and Outlook till 2022

    • 10.1 Global Neurovascular Thrombectomy Device Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.2.2 Canada Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.2.3 Mexico Neurovascular Thrombectomy Device Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.3.2 UK Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.3.3 Spain Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.3.4 Belgium Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.3.5 France Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.3.6 Italy Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.3.7 Denmark Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.3.8 Finland Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.3.9 Norway Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.3.10 Sweden Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.3.11 Poland Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.3.12 Russia Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.3.13 Turkey Neurovascular Thrombectomy Device Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.4.2 Japan Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.4.3 India Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.4.4 South Korea Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.4.5 Pakistan Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.4.6 Bangladesh Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.4.7 Indonesia Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.4.8 Thailand Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.4.9 Singapore Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.4.10 Malaysia Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.4.11 Philippines Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.4.12 Vietnam Neurovascular Thrombectomy Device Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.5.2 Colombia Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.5.3 Chile Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.5.4 Argentina Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.5.5 Venezuela Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.5.6 Peru Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.5.7 Puerto Rico Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.5.8 Ecuador Neurovascular Thrombectomy Device Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.6.2 Kuwait Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.6.3 Oman Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.6.4 Qatar Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Neurovascular Thrombectomy Device Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.7.2 South Africa Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.7.3 Egypt Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.7.4 Algeria Neurovascular Thrombectomy Device Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Neurovascular Thrombectomy Device Consumption (2017-2022)

      • 10.8.2 New Zealand Neurovascular Thrombectomy Device Consumption (2017-2022)

    11 Global Neurovascular Thrombectomy Device Competitive Analysis

    • 11.1 Spectranetics Corporation (US)

      • 11.1.1 Spectranetics Corporation (US) Company Details

      • 11.1.2 Spectranetics Corporation (US) Neurovascular Thrombectomy Device Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Spectranetics Corporation (US) Neurovascular Thrombectomy Device Main Business and Markets Served

      • 11.1.4 Spectranetics Corporation (US) Neurovascular Thrombectomy Device Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Penumbra, Inc (US)

      • 11.2.1 Penumbra, Inc (US) Company Details

      • 11.2.2 Penumbra, Inc (US) Neurovascular Thrombectomy Device Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Penumbra, Inc (US) Neurovascular Thrombectomy Device Main Business and Markets Served

      • 11.2.4 Penumbra, Inc (US) Neurovascular Thrombectomy Device Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Edwards Lifesciences Corporation (US)

      • 11.3.1 Edwards Lifesciences Corporation (US) Company Details

      • 11.3.2 Edwards Lifesciences Corporation (US) Neurovascular Thrombectomy Device Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Edwards Lifesciences Corporation (US) Neurovascular Thrombectomy Device Main Business and Markets Served

      • 11.3.4 Edwards Lifesciences Corporation (US) Neurovascular Thrombectomy Device Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Terumo Corporation (Japan)

      • 11.4.1 Terumo Corporation (Japan) Company Details

      • 11.4.2 Terumo Corporation (Japan) Neurovascular Thrombectomy Device Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Terumo Corporation (Japan) Neurovascular Thrombectomy Device Main Business and Markets Served

      • 11.4.4 Terumo Corporation (Japan) Neurovascular Thrombectomy Device Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Medtronic plc (Ireland)

      • 11.5.1 Medtronic plc (Ireland) Company Details

      • 11.5.2 Medtronic plc (Ireland) Neurovascular Thrombectomy Device Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Medtronic plc (Ireland) Neurovascular Thrombectomy Device Main Business and Markets Served

      • 11.5.4 Medtronic plc (Ireland) Neurovascular Thrombectomy Device Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Stryker Corporation (US)

      • 11.6.1 Stryker Corporation (US) Company Details

      • 11.6.2 Stryker Corporation (US) Neurovascular Thrombectomy Device Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Stryker Corporation (US) Neurovascular Thrombectomy Device Main Business and Markets Served

      • 11.6.4 Stryker Corporation (US) Neurovascular Thrombectomy Device Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Teleflex Incorporated (US)

      • 11.7.1 Teleflex Incorporated (US) Company Details

      • 11.7.2 Teleflex Incorporated (US) Neurovascular Thrombectomy Device Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Teleflex Incorporated (US) Neurovascular Thrombectomy Device Main Business and Markets Served

      • 11.7.4 Teleflex Incorporated (US) Neurovascular Thrombectomy Device Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Johnson & Johnson (US)

      • 11.8.1 Johnson & Johnson (US) Company Details

      • 11.8.2 Johnson & Johnson (US) Neurovascular Thrombectomy Device Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Johnson & Johnson (US) Neurovascular Thrombectomy Device Main Business and Markets Served

      • 11.8.4 Johnson & Johnson (US) Neurovascular Thrombectomy Device Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Argon Medical Devices, Inc (US)

      • 11.9.1 Argon Medical Devices, Inc (US) Company Details

      • 11.9.2 Argon Medical Devices, Inc (US) Neurovascular Thrombectomy Device Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Argon Medical Devices, Inc (US) Neurovascular Thrombectomy Device Main Business and Markets Served

      • 11.9.4 Argon Medical Devices, Inc (US) Neurovascular Thrombectomy Device Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Boston Scientific Corporation (US)

      • 11.10.1 Boston Scientific Corporation (US) Company Details

      • 11.10.2 Boston Scientific Corporation (US) Neurovascular Thrombectomy Device Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Boston Scientific Corporation (US) Neurovascular Thrombectomy Device Main Business and Markets Served

      • 11.10.4 Boston Scientific Corporation (US) Neurovascular Thrombectomy Device Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Neurovascular Thrombectomy Device Market Outlook by Types and Applications to 2028

    • 12.1 Global Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Mechanical/Fragmentation Thrombectomy Devices Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Stent Retrievers Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Basket/Brush Retrievers Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Coil Retrievers Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Aspiration Thrombectomy Devices Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Rheolytic/Hydrodynamic Thrombectomy Devices Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Ultrasonic Thrombectomy Devices Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals and Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Research Laboratories & Academic Institutes Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Neurovascular Thrombectomy Device Market Analysis and Outlook to 2028

    • 13.1 Global Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.2.2 Canada Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.3.2 UK Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.3.3 Spain Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.3.5 France Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.3.6 Italy Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.3.8 Finland Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.3.9 Norway Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.3.11 Poland Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.3.12 Russia Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.4.2 Japan Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.4.3 India Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.5.3 Chile Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.5.6 Peru Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.6.3 Oman Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Neurovascular Thrombectomy Device Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Neurovascular Thrombectomy Device

    • Figure of Neurovascular Thrombectomy Device Picture

    • Table Global Neurovascular Thrombectomy Device Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Neurovascular Thrombectomy Device Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Mechanical/Fragmentation Thrombectomy Devices Consumption and Growth Rate (2017-2022)

    • Figure Global Stent Retrievers Consumption and Growth Rate (2017-2022)

    • Figure Global Basket/Brush Retrievers Consumption and Growth Rate (2017-2022)

    • Figure Global Coil Retrievers Consumption and Growth Rate (2017-2022)

    • Figure Global Aspiration Thrombectomy Devices Consumption and Growth Rate (2017-2022)

    • Figure Global Rheolytic/Hydrodynamic Thrombectomy Devices Consumption and Growth Rate (2017-2022)

    • Figure Global Ultrasonic Thrombectomy Devices Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals and Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Research Laboratories & Academic Institutes Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Neurovascular Thrombectomy Device Consumption by Country (2017-2022)

    • Table North America Neurovascular Thrombectomy Device Consumption by Country (2017-2022)

    • Figure United States Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Canada Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Mexico Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Table Europe Neurovascular Thrombectomy Device Consumption by Country (2017-2022)

    • Figure Germany Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure UK Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Spain Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Belgium Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure France Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Italy Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Denmark Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Finland Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Norway Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Sweden Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Poland Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Russia Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Turkey Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Table APAC Neurovascular Thrombectomy Device Consumption by Country (2017-2022)

    • Figure China Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Japan Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure India Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure South Korea Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Thailand Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Singapore Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Philippines Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Table South America Neurovascular Thrombectomy Device Consumption by Country (2017-2022)

    • Figure Brazil Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Colombia Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Chile Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Argentina Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Peru Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Table GCC Neurovascular Thrombectomy Device Consumption by Country (2017-2022)

    • Figure Bahrain Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Oman Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Qatar Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Table Africa Neurovascular Thrombectomy Device Consumption by Country (2017-2022)

    • Figure Nigeria Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure South Africa Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Egypt Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure Algeria Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Table Oceania Neurovascular Thrombectomy Device Consumption by Country (2017-2022)

    • Figure Australia Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Neurovascular Thrombectomy Device Consumption and Growth Rate (2017-2022)

    • Table Spectranetics Corporation (US) Company Details

    • Table Spectranetics Corporation (US) Neurovascular Thrombectomy Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Spectranetics Corporation (US) Neurovascular Thrombectomy Device Main Business and Markets Served

    • Table Spectranetics Corporation (US) Neurovascular Thrombectomy Device Product Portfolio

    • Table Penumbra, Inc (US) Company Details

    • Table Penumbra, Inc (US) Neurovascular Thrombectomy Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Penumbra, Inc (US) Neurovascular Thrombectomy Device Main Business and Markets Served

    • Table Penumbra, Inc (US) Neurovascular Thrombectomy Device Product Portfolio

    • Table Edwards Lifesciences Corporation (US) Company Details

    • Table Edwards Lifesciences Corporation (US) Neurovascular Thrombectomy Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Edwards Lifesciences Corporation (US) Neurovascular Thrombectomy Device Main Business and Markets Served

    • Table Edwards Lifesciences Corporation (US) Neurovascular Thrombectomy Device Product Portfolio

    • Table Terumo Corporation (Japan) Company Details

    • Table Terumo Corporation (Japan) Neurovascular Thrombectomy Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Terumo Corporation (Japan) Neurovascular Thrombectomy Device Main Business and Markets Served

    • Table Terumo Corporation (Japan) Neurovascular Thrombectomy Device Product Portfolio

    • Table Medtronic plc (Ireland) Company Details

    • Table Medtronic plc (Ireland) Neurovascular Thrombectomy Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic plc (Ireland) Neurovascular Thrombectomy Device Main Business and Markets Served

    • Table Medtronic plc (Ireland) Neurovascular Thrombectomy Device Product Portfolio

    • Table Stryker Corporation (US) Company Details

    • Table Stryker Corporation (US) Neurovascular Thrombectomy Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stryker Corporation (US) Neurovascular Thrombectomy Device Main Business and Markets Served

    • Table Stryker Corporation (US) Neurovascular Thrombectomy Device Product Portfolio

    • Table Teleflex Incorporated (US) Company Details

    • Table Teleflex Incorporated (US) Neurovascular Thrombectomy Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teleflex Incorporated (US) Neurovascular Thrombectomy Device Main Business and Markets Served

    • Table Teleflex Incorporated (US) Neurovascular Thrombectomy Device Product Portfolio

    • Table Johnson & Johnson (US) Company Details

    • Table Johnson & Johnson (US) Neurovascular Thrombectomy Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson (US) Neurovascular Thrombectomy Device Main Business and Markets Served

    • Table Johnson & Johnson (US) Neurovascular Thrombectomy Device Product Portfolio

    • Table Argon Medical Devices, Inc (US) Company Details

    • Table Argon Medical Devices, Inc (US) Neurovascular Thrombectomy Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Argon Medical Devices, Inc (US) Neurovascular Thrombectomy Device Main Business and Markets Served

    • Table Argon Medical Devices, Inc (US) Neurovascular Thrombectomy Device Product Portfolio

    • Table Boston Scientific Corporation (US) Company Details

    • Table Boston Scientific Corporation (US) Neurovascular Thrombectomy Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boston Scientific Corporation (US) Neurovascular Thrombectomy Device Main Business and Markets Served

    • Table Boston Scientific Corporation (US) Neurovascular Thrombectomy Device Product Portfolio

    • Figure Global Mechanical/Fragmentation Thrombectomy Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Stent Retrievers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Basket/Brush Retrievers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Coil Retrievers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Aspiration Thrombectomy Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rheolytic/Hydrodynamic Thrombectomy Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ultrasonic Thrombectomy Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals and Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Laboratories & Academic Institutes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neurovascular Thrombectomy Device Consumption Forecast by Country (2022-2028)

    • Table North America Neurovascular Thrombectomy Device Consumption Forecast by Country (2022-2028)

    • Figure United States Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Neurovascular Thrombectomy Device Consumption Forecast by Country (2022-2028)

    • Figure Germany Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Neurovascular Thrombectomy Device Consumption Forecast by Country (2022-2028)

    • Figure China Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Neurovascular Thrombectomy Device Consumption Forecast by Country (2022-2028)

    • Figure Brazil Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Neurovascular Thrombectomy Device Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Neurovascular Thrombectomy Device Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Neurovascular Thrombectomy Device Consumption Forecast by Country (2022-2028)

    • Figure Australia Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Neurovascular Thrombectomy Device Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US